Suchergebnisse - "Bergmann, Lothar"

PubPharm (130)

51

Defining the critical hurdles in cancer immunotherapy

enthalten in: Journal of translational medicine | 2011

von Fox, B. | Schendel, D. | Butterfield, L. | +102

52

Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia

enthalten in: European journal of haematology | 2011

von Chow, K. | Kim, S. | von Neuhoff, N. | +5

53

Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia

enthalten in: European journal of haematology | 2011

von Chow, K. | Kim, S. | von Neuhoff, N. | +5

54

The preclinical and clinical activity of aviscumine : a potential anticancer drug

enthalten in: European journal of cancer (Oxford, England : 1990) | 2011

von Zwierzina, H. | Bergmann, L. | Fiebig, H. | +4

55

The preclinical and clinical activity of aviscumine: A potential anticancer drug

enthalten in: The European journal of cancer / A | 2011

von Zwierzina, H. | Bergmann, L. | Fiebig, H. | +4

56

Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell lines

enthalten in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine | 2011

von Glienke, W. | Hausmann, E. | Bergmann, L.

57

Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)

enthalten in: Investigational new drugs | 2011

von Schultheis, B. | Strumberg, D. | Bergmann, L. | +7

58

Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)

enthalten in: Investigational new drugs | 2011

von Schultheis, B. | Strumberg, D. | Bergmann, L. | +7

59

Results of a phase II trial of S-1 as first-line treatment of metastatic pancreatic cancer (CESAR-study group)

enthalten in: Investigational new drugs | 2011

von Schultheis, B. | Strumberg, D. | Bergmann, L. | +7

60

Targeting STAT3 signaling in pancreatic cancer promotes antiapoptotic gene expression

enthalten in: Pancreas | 2011

von Glienke, W. | Hausmann, E. | Bergmann, L.